Pharmacogenomic study in multiple sclerosis patients responders and non-responders to interferon-β

被引：0
|
作者：
Bustamante, M.
Morcillo-Suarez, C.
Malhotra, S.
Brassat, D.
Goertsches, R.
Lechner-Scott, J.
Urcelay, E.
Fernandez, O.
Drulovic, J.
Garcia-Merino, A.
Martinelli-Boneschi, F.
Chan, A.
Vandenbroeck, K.
Navarro, A.
Rio, J.
Akkad, D.
Giacalone, G.
Sanchez, A.
Leyva, L.
Alvarez-Lafuente, R.
Zettl, U.
Rodriguez-Antigueedad, A.
Killestein, J.
Oksenberg, J.
Montalban, X.
Comabella, M.
机构：
[1] Vall Hebron Univ Hosp, Barcelona, Spain
[2] Inst Evolutionary Biol UPF CSIC, Barcelona, Spain
[3] Univ Toulouse, Toulouse, France
[4] Univ Rostock, D-18055 Rostock, Germany
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp Reg Univ Carlos Haya, Malaga, Spain
[7] Univ Belgrade, Belgrade, Serbia
[8] Hosp Univ Puerta de Hierro, Madrid, Spain
[9] Ist Sci San Raffaele, I-20132 Milan, Italy
[10] Univ Bochum, Bochum, Germany
[11] Univ Basque Country, Leioa, Spain
[12] ICREA, Barcelona, Spain
[13] Hosp Basurto, Bilbao, Spain
[14] Vrije Univ Med Ctr, Amsterdam, Netherlands
[15] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [41] FETOMATERNAL HEMORRHAGE IN RH NEGATIVE RESPONDERS AND NON-RESPONDERS
    GUPTA, I
    GANGULY, NK
    JOLLY, JG
    GUPTA, AN
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1985, 82 (JUL) : 29 - 31
  • [42] Galcanezumab effects on incidence of headache after occurrence of triggers, prodromes, and aura in responders, non-responders, super-responders and super non-responders
    Ashina, Sait
    Carrillo, Agustin Melo
    Ajayi, Toluwanimi
    Szabo, Edina
    Borsook, David
    Burstein, Rami
    NEUROLOGY, 2023, 100 (17)
  • [43] THE PHARMACOKINETICS OF RANITIDINE IN PATIENTS WITH CHRONIC DUODENAL ULCERATION - A COMPARISON OF RESPONDERS AND NON-RESPONDERS
    MCFADYEN, ML
    FOLB, PI
    MILLER, R
    MARKS, IN
    MOSHAL, MG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (04) : 441 - 447
  • [44] Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders
    Hoexter, Marcelo Q.
    Lopes, Antonio C.
    Shavitt, Roseli G.
    Batistuzzo, Marcelo C.
    Dougherty, Darin D.
    Diniz, Juliana B.
    Duran, Fabio F. S.
    Busatto, Geraldo F.
    Bressan, Rodrigo A.
    Sato, Joao R.
    Miguel, Euripedes C.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 78S - 78S
  • [45] The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non-Responders
    Balasa, Rodica
    Bianca, Ciurba
    Septimiu, Voidezan
    Iunius, Simu
    Adina, Hutanu
    Sebastian, Andone
    Andreea, Romaniuc
    Anca, Motataianu
    Smaranda, Maier
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (06) : 464 - 472
  • [46] Early recognition of non-responders in oncological patients
    Diederich, S.
    RADIOLOGE, 2010, 50 (02): : 101 - 102
  • [47] Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
    Ashina, Sait
    Melo-Carrillo, Agustin
    Toluwanimi, Ajayi
    Bolo, Nicolas
    Szabo, Edina
    Borsook, David
    Burstein, Rami
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
  • [48] Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders
    Lo, A. C.
    Ruiz, J. A.
    Koenig, C. M.
    Anderson, B. M.
    Olson, K. M.
    Triche, E. W.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 356 (1-2) : 77 - 82
  • [49] Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders
    Sait Ashina
    Agustin Melo-Carrillo
    Ajayi Toluwanimi
    Nicolas Bolo
    Edina Szabo
    David Borsook
    Rami Burstein
    The Journal of Headache and Pain, 24
  • [50] Options for non-responders to monotherapy
    Bacon, B
    NON-RESPONDING HEPATITIS C PATIENT: OPTIONS AND VARIABLES, 2000, (70): : 5 - 13
12345